SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 72.72   1.51 (+2.12%) Volume: 804.64k 4:00 PM EDT Mar 31, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
4Statement of changes in beneficial ownership of securities106/07/2019
DEFA14AAdditional proxy soliciting materials - definitive206/04/2019
8-KCurrent report pursuant to Section 13 or 15(d)406/03/2019
4Statement of changes in beneficial ownership of securities105/31/2019
4Statement of changes in beneficial ownership of securities105/31/2019
8-KCurrent report pursuant to Section 13 or 15(d)405/24/2019
4Statement of changes in beneficial ownership of securities105/22/2019
4Statement of changes in beneficial ownership of securities105/16/2019
4Statement of changes in beneficial ownership of securities105/14/2019
4Statement of changes in beneficial ownership of securities105/14/2019
123456789101112131415